Julia Petryk
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgery.
Journal: Journal for immunotherapy of cancer
Published: January 01, 2026
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2025
RNAi Screening in Tumor Cells Identifies Artificial microRNAs That Improve Oncolytic Virus Replication.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 11, 2025
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.
Journal: Nature biomedical engineering
Published: March 25, 2024
Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.
Journal: Nature communications
Published: October 12, 2023
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.
Journal: Molecular therapy. Methods & clinical development
Published: May 02, 2023
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 20, 2023
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development.
Journal: The Journal of biological chemistry
Published: February 08, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Journal: Nature communications
Published: December 15, 2022
Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment.
Journal: Frontiers in immunology
Published: November 15, 2022
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Journal: Frontiers in immunology
Published: September 21, 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Journal: Frontiers in immunology
Published: August 27, 2022
Last Updated: 09/26/2026